Cardlytics (CDLX) Shares Outstanding (Diluted Average) (2017 - 2026)

Cardlytics has reported Shares Outstanding (Diluted Average) for 9 years, with the latest figure at $54.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 5.85% year-over-year to $54.9 million; the trailing twelve-month figure through Mar 2026 stood at $54.9 million (up 5.85% YoY), and the FY2025 full-year result was $53.1 million, up 9.83% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $54.9 million, up from $53.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $54.9 million in Q1 2026, with the low at $33.4 million in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $43.4 million across 5 years, with a median of $43.2 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) dropped 1.23% — and 2024, when it soared 40.64%.
• Cardlytics' Shares Outstanding (Diluted Average) stood at $33.4 million in 2022, then advanced by 9.18% to $36.5 million in 2023, then surged by 32.54% to $48.4 million in 2024, then grew by 9.83% to $53.1 million in 2025, then rose by 3.36% to $54.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $54.9 million (Q1 2026), $53.1 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.